Martin has previously led corporate strategy, innovation, operations, quality and regulatory, M&A and global expansion assignments for medical device and life sciences companies. Martin founded Bruin Biometrics (BBI) in 2009, and the company’s pipeline is comprised of solutions for wound care, orthopedic care and real-time data capture, analytics and reporting. In the European market since 2014, BBI’s first product to market is the SEM Scanner*, a hand-held, portable, skin tissue assessment device that measures sub-epidermal moisture which is an invisible precursor to the development of incipient pressure damage. *SEM Scanner Pending FDA decision, not for sale in the US.